These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 20358644)
21. MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition. Dai M; Miao ZH; Ren X; Tong LJ; Yang N; Li T; Lin LP; Shen YM; Ding J J Cell Mol Med; 2010 Sep; 14(9):2281-91. PubMed ID: 19538463 [TBL] [Abstract][Full Text] [Related]
22. The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells. Thobe MN; Gurusamy D; Pathrose P; Waltz SE Oncogene; 2010 Jan; 29(2):214-26. PubMed ID: 19838218 [TBL] [Abstract][Full Text] [Related]
23. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation. Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804 [TBL] [Abstract][Full Text] [Related]
24. Angiopoietin-1 induces Kruppel-like factor 2 expression through a phosphoinositide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2. Sako K; Fukuhara S; Minami T; Hamakubo T; Song H; Kodama T; Fukamizu A; Gutkind JS; Koh GY; Mochizuki N J Biol Chem; 2009 Feb; 284(9):5592-601. PubMed ID: 19106103 [TBL] [Abstract][Full Text] [Related]
25. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts. Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873 [TBL] [Abstract][Full Text] [Related]
27. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Huang SW; Lien JC; Kuo SC; Huang TF Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611 [TBL] [Abstract][Full Text] [Related]
28. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration. Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma. Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438 [TBL] [Abstract][Full Text] [Related]
30. Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer. Zang C; Eucker J; Habbel P; Neumann C; Schulz CO; Bangemann N; Kissner L; Riess H; Liu H Cell Cycle; 2015; 14(8):1291-9. PubMed ID: 25714853 [TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study. Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000 [TBL] [Abstract][Full Text] [Related]
32. The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways. Kim CK; Choi YK; Lee H; Ha KS; Won MH; Kwon YG; Kim YM Mol Pharmacol; 2010 Jul; 78(1):142-50. PubMed ID: 20406854 [TBL] [Abstract][Full Text] [Related]
33. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Sodhi A; Montaner S; Patel V; Zohar M; Bais C; Mesri EA; Gutkind JS Cancer Res; 2000 Sep; 60(17):4873-80. PubMed ID: 10987301 [TBL] [Abstract][Full Text] [Related]
34. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. von Marschall Z; Cramer T; Höcker M; Burde R; Plath T; Schirner M; Heidenreich R; Breier G; Riecken EO; Wiedenmann B; Rosewicz S Gastroenterology; 2000 Nov; 119(5):1358-72. PubMed ID: 11054395 [TBL] [Abstract][Full Text] [Related]
35. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. Guo Y; Wang S; Hoot DR; Clinton SK J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033 [TBL] [Abstract][Full Text] [Related]
36. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity. Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200 [TBL] [Abstract][Full Text] [Related]
37. The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression. Thomas RM; Toney K; Fenoglio-Preiser C; Revelo-Penafiel MP; Hingorani SR; Tuveson DA; Waltz SE; Lowy AM Cancer Res; 2007 Jul; 67(13):6075-82. PubMed ID: 17616662 [TBL] [Abstract][Full Text] [Related]
38. Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma. Bausch D; Pausch T; Krauss T; Hopt UT; Fernandez-del-Castillo C; Warshaw AL; Thayer SP; Keck T Angiogenesis; 2011 Sep; 14(3):235-43. PubMed ID: 21442180 [TBL] [Abstract][Full Text] [Related]
39. Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups. Bisping G; Kropff M; Wenning D; Dreyer B; Bessonov S; Hilberg F; Roth GJ; Munzert G; Stefanic M; Stelljes M; Scheffold C; Müller-Tidow C; Liebisch P; Lang N; Tchinda J; Serve HL; Mesters RM; Berdel WE; Kienast J Blood; 2006 Mar; 107(5):2079-89. PubMed ID: 16278310 [TBL] [Abstract][Full Text] [Related]
40. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis. Kou B; Ni J; Vatish M; Singer DR Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]